GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (OTCPK:DTCFF) » Definitions » Issuance of Debt

Defence Therapeutics (Defence Therapeutics) Issuance of Debt : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Issuance of Debt?

Defence Therapeutics's Issuance of Debt for the three months ended in Mar. 2024 was $0.00 Mil.

Defence Therapeutics's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.


Defence Therapeutics Issuance of Debt Historical Data

The historical data trend for Defence Therapeutics's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Issuance of Debt Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Issuance of Debt
- - -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Defence Therapeutics Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Defence Therapeutics (Defence Therapeutics) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Defence Therapeutics (Defence Therapeutics) Headlines

No Headlines